Table 1—

Patient characteristics at randomization into the study

VariableConventional glucose control policyIntensive glucose control policy
All
Insulin aloneChlorpropamide (± insulin)Glipizide (± insulin)
n242245169170826
Sex (% male)5960566359
Ethnic group (%)
    White Caucasian7780797779
    Afro-Caribbean54555
    Indian Asian1816161816
Age (years)52 ± 952 ± 952 ± 1052 ± 1052 ± 9
Fasting plasma glucose (mg/dl)149 (131–184)151 (130–185)149 (130–182)149 (128–176)149 (130–182)
HbA1c (%)7.0 (6.2–8.1)6.9 (6.1–8.0)6.9 (6.0–8.1)6.9 (6.0–7.7)6.9 (6.1–8.0)
Weight (lb)180 ± 40180 ± 40176 ± 37178 ± 37178 ± 37
BMI (kg/m2)28.8 ± 5.929.3 ± 6.428.4 ± 4.928.5 ± 5.528.8 ± 5.8
Systolic blood pressure (mmHg)132 ± 19134 ± 21133 ± 20131 ± 19132 ± 20
Diastolic blood pressure (mmHg)80 ± 1082 ± 1181 ± 1080 ± 1081 ± 10
  • Data are means ± SD or median (IQR).